MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,017,848 | -34.6% | 127,309 | -3.4% | 0.00% | -25.0% |
| Q2 2023 | $3,087,104 | -26.1% | 131,843 | -26.5% | 0.00% | -33.3% |
| Q1 2023 | $4,178,667 | +63.0% | 179,265 | -1.5% | 0.01% | +50.0% |
| Q4 2022 | $2,563,025 | -35.6% | 182,033 | -9.5% | 0.00% | -33.3% |
| Q3 2022 | $3,978,000 | +8.5% | 201,129 | -0.5% | 0.01% | +20.0% |
| Q2 2022 | $3,666,000 | -36.6% | 202,198 | -9.7% | 0.01% | -28.6% |
| Q1 2022 | $5,783,000 | -7.6% | 223,971 | +1.4% | 0.01% | -12.5% |
| Q4 2021 | $6,261,000 | -14.9% | 220,922 | -0.7% | 0.01% | -20.0% |
| Q3 2021 | $7,359,000 | +9.7% | 222,591 | +1.4% | 0.01% | +11.1% |
| Q2 2021 | $6,711,000 | +64.8% | 219,442 | +61.4% | 0.01% | +50.0% |
| Q1 2021 | $4,072,000 | +48.9% | 135,994 | -1.7% | 0.01% | +50.0% |
| Q4 2020 | $2,735,000 | +47.9% | 138,319 | -2.6% | 0.00% | +33.3% |
| Q3 2020 | $1,849,000 | -40.2% | 142,003 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $3,092,000 | +51.1% | 284,006 | +104.0% | 0.00% | -40.0% |
| Q1 2020 | $2,047,000 | -43.6% | 139,186 | +3.0% | 0.01% | -28.6% |
| Q4 2019 | $3,627,000 | -3.4% | 135,091 | +3.1% | 0.01% | -12.5% |
| Q3 2019 | $3,753,000 | +3.8% | 130,989 | +0.7% | 0.01% | 0.0% |
| Q2 2019 | $3,614,000 | -17.1% | 130,070 | -0.9% | 0.01% | -11.1% |
| Q1 2019 | $4,358,000 | -53.2% | 131,269 | -59.0% | 0.01% | +12.5% |
| Q4 2018 | $9,312,000 | -0.3% | 320,271 | +57.8% | 0.01% | -20.0% |
| Q3 2018 | $9,338,000 | +204.5% | 202,966 | +147.3% | 0.01% | +42.9% |
| Q2 2018 | $3,067,000 | +19.5% | 82,066 | -5.5% | 0.01% | +16.7% |
| Q1 2018 | $2,567,000 | +4.9% | 86,877 | +21.9% | 0.01% | 0.0% |
| Q4 2017 | $2,448,000 | -13.4% | 71,278 | -8.8% | 0.01% | -14.3% |
| Q3 2017 | $2,828,000 | +51.7% | 78,178 | +8.4% | 0.01% | +40.0% |
| Q2 2017 | $1,864,000 | +15.3% | 72,152 | -14.3% | 0.01% | +25.0% |
| Q1 2017 | $1,617,000 | +36.1% | 84,197 | +18.1% | 0.00% | +33.3% |
| Q4 2016 | $1,188,000 | +3.0% | 71,294 | +27.2% | 0.00% | 0.0% |
| Q3 2016 | $1,153,000 | -5.0% | 56,045 | +41.2% | 0.00% | +50.0% |
| Q2 2016 | $1,214,000 | – | 39,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |